Generex Biotechnology Corp (GNBTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 07-2020 | 07-2019 | 07-2018 | 07-2017 | 07-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,232 | -11,007 | 35,949 | -76,833 | -3,223 |
| Depreciation Amortization | 9,658 | 3,736 | 24 | 13,385 | 265 |
| Accounts receivable | -6 | -750 | -34 | 1 | N/A |
| Other Working Capital | 10,085 | 11,076 | 762 | 994 | 1,100 |
| Other Operating Activity | 8,374 | -12,629 | -38,994 | 61,282 | 1,082 |
| Operating Cash Flow | $-6,121 | $-9,574 | $-2,293 | $-1,170 | $-776 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | 3 | -9 | N/A | N/A |
| Net Acquisitions | N/A | N/A | N/A | 12 | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -4,000 | N/A |
| Sale Of Investment | N/A | N/A | N/A | 4,000 | N/A |
| Purchase Sale Intangibles | N/A | 36 | N/A | N/A | N/A |
| Other Investing Activity | 49 | 2,316 | 0 | 0 | 0 |
| Investing Cash Flow | $45 | $2,319 | $-9 | $12 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,636 | 6,560 | 126 | 1,675 | 50 |
| Debt Repayment | N/A | N/A | N/A | -689 | N/A |
| Common Stock Issued | 110 | N/A | N/A | 50 | 3 |
| Other Financing Activity | -936 | -52 | 328 | 3,000 | 0 |
| Financing Cash Flow | $5,811 | $6,509 | $454 | $4,036 | $53 |
| Exchange Rate Effect | -17 | -1 | 15 | -16 | -11 |
| Beginning Cash Position | 299 | 1,046 | 2,879 | 17 | 750 |
| End Cash Position | 16 | 299 | 1,046 | 2,879 | 17 |
| Net Cash Flow | $-283 | $-748 | $-1,833 | $2,862 | $-733 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,121 | -9,574 | -2,293 | -1,170 | -776 |
| Capital Expenditure | -5 | -290 | -9 | N/A | N/A |
| Free Cash Flow | -6,126 | -9,864 | -2,302 | -1,170 | -776 |